Adjusting Starting Points for Initial Price Offers: The Example of Ibrutinib
April 2nd 2024Ibrutinib has been selected for Medicare price negotiation under the Inflation Reduction Act. The authors summarize the House Oversight Committee investigation to be considered by CMS during the price negotiation process.